immatics biotechnologies GmbH And responsif GmbH Sign A Cooperation Agreement Within The Scope Of The BioChancePLUS Grant Program
5/22/2006 2:30:07 PM
More...
|
responsif GmbH Obtains US-Patent For Its NanosVir Technology
3/15/2006 1:35:40 PM
More...
|
responsif GmbH Starting To Recruit Patients With Renal Cell Carcinoma For A Clinical Study
10/19/2005 5:11:31 PM
More...
|
Artificial Capsoid Proteins Transport Drug Actives Into Living Cells -- Research Milestone At responsif GmbH
10/19/2005 5:11:05 PM
More...
|
responsif GmbH Release: Cancer Researchers At An University In Stockholm, Sweden, And Biotechnology Experts In Erlangen, Germany, Join Forces To Fight Cancer
10/19/2005 5:10:28 PM
More...
|